-
公开(公告)号:EP1609785A4
公开(公告)日:2008-10-22
申请号:EP04720254
申请日:2004-03-12
发明人: IMAMURA MASAKAZU , MURAKAMI TAKESHI , SHIRAKI RYOTA , IKEGAI KAZUHIRO , SUGANE TAKASHI , IWASAKI FUMIYOSHI , KUROSAKI EIJI , TOMIYAMA HIROSHI , NODA ATSUSHI , KITTA KAYOKO , KOBAYASHI YOSHINORI
IPC分类号: A61K31/351 , A61K31/381 , A61K31/4035 , A61K31/404 , A61K31/41 , A61K31/4184 , A61K31/423 , A61K31/428 , A61K31/4433 , A61K31/497 , A61K31/5377 , A61P3/04 , A61P3/10 , C07D207/06 , C07D309/10 , C07D333/12 , C07D333/16 , C07D333/54 , C07D405/04 , C07D405/10 , C07D407/04 , C07D409/04 , C07D409/10 , C07D409/14 , C07D413/10 , C07D417/10 , C07D493/04 , C07D495/04 , A61K31/49 , C07D407/10
CPC分类号: C07D495/04 , A61K31/351 , A61K31/381 , A61K31/4035 , A61K31/404 , A61K31/41 , A61K31/4184 , A61K31/423 , A61K31/428 , A61K31/4433 , A61K31/497 , A61K31/5377 , C07D405/10 , C07D407/10 , C07D409/10 , C07D413/10 , C07D417/10
摘要: A C-glycoside derivative represented by the following general formula (I) or its salt which is a compound useful as a Na+-glucose co-transportation inhibitor in a remedy for, e.g., diabetes, in particular, insulin-independent diabetes (type 2 diabetes) and insulin-dependent diabetes (type 1 diabetes), as well as a remedy for insulin resistance diseases and various diseases relating to diabetes including obesity. This compound is characterized in that the ring B is bonded to the ring A via -X- and the ring A is bonded directly to a sugar residue.
-
公开(公告)号:EP1553094A4
公开(公告)日:2006-10-11
申请号:EP03766722
申请日:2003-08-04
发明人: TOMIYAMA HIROSHI , NODA ATSUSHI , KITTA KAYOKO , KOBAYASHI YOSHINORI , IMAMURA MASAKAZU , MURAKAMI TAKESHI , IKEGAI KAZUHIRO , SUZUKI TAKAYUKI , KUROSAKI EIJI
IPC分类号: C07D309/12 , A61K31/351 , A61P3/04 , A61P3/10 , A61P43/00 , C07D309/10
CPC分类号: C07D309/12 , C07D309/10
摘要: Azulene derivatives represented by the following general formula (I) and salts thereof are useful as Na+-glucose cotransporter inhibitors in, for example, remedies for diabetes, etc., in particular, insulin-independent diabetes (type 2 diabetes), insulin-dependent diabetes (type 1 diabetes), etc., and remedies for various diabetes-related diseases such as insulin resistant disease and obesity. These compounds are characterized in that an azulene ring is bonded, either directly or via an optionally halogenated lower alkylene, to a benzene ring and the benzene ring is directly bonded to a sugar residue.
-
公开(公告)号:EP1632477A4
公开(公告)日:2008-07-16
申请号:EP04736576
申请日:2004-06-10
申请人: ASTELLAS PHARMA INC
发明人: KURAMOCHI TAKAHIRO , ASAI NORIO , IKEGAI KAZUHIRO , AKAMATSU SEIJIRO , HARADA HIRONORI , ISHIKAWA NORIKO , SHIRAKAMI SHOHEI , MIYAMOTO SATOSHI , WATANABE TOSHIHIRO , KISO TETSUO
IPC分类号: C07C237/40 , A61K31/167 , A61K31/428 , A61K31/4453 , A61K31/454 , A61K31/4709 , A61K31/4725 , A61K31/496 , A61K31/5377 , A61K31/538 , A61K31/55 , A61P1/04 , A61P11/00 , A61P11/06 , A61P13/10 , A61P17/04 , A61P25/06 , A61P29/00 , C07D209/08 , C07D209/34 , C07D209/36 , C07D213/75 , C07D215/38 , C07D217/04 , C07D223/16 , C07D231/56 , C07D235/06 , C07D241/42 , C07D249/18 , C07D263/58 , C07D265/36 , C07D277/62 , C07D277/64 , C07D277/82 , C07D279/16 , C07D295/155 , C07D307/79 , C07D317/64 , C07D317/66 , C07D333/54 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04
CPC分类号: C07C237/40 , A61K31/167 , A61K31/428 , A61K31/4453 , A61K31/454 , A61K31/4709 , A61K31/4725 , A61K31/496 , A61K31/5377 , A61K31/538 , A61K31/55 , C07D209/08 , C07D209/34 , C07D213/75 , C07D215/38 , C07D217/04 , C07D223/16 , C07D231/56 , C07D235/06 , C07D241/42 , C07D249/18 , C07D263/58 , C07D265/36 , C07D277/64 , C07D277/82 , C07D279/16 , C07D295/155 , C07D307/79 , C07D317/66 , C07D333/54 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04
摘要: A compound which functions to inhibit capsaicin receptor VR1 activation and is useful as a therapeutic agent for, e.g., various pains including inflammatory pain and neurogenic pain, migraine, cluster headache, and bladder diseases including overactive bladder. It is a benzamide derivative or salt thereof, the derivative being characterized by comprising: a benzene ring; a ring D (a mono- or dicyclic hydrocarbon ring or mono- or dicyclic heteroaromatic ring) bonded to the benzene ring through an amide bond; a ring E (a mono- or dicyclic hydrocarbon ring or mono- or dicyclic heteroaromatic ring) directly bonded to the benzene ring; and A (an amino moiety or a mono- or dicyclic heteroring) bonded to the benzene ring through L (a lower alkylene).
摘要翻译: 一种起抑制辣椒素受体VR1激活作用的化合物,可用作例如各种疼痛的治疗剂,包括炎性疼痛和神经原性疼痛,偏头痛,丛集性头痛和膀胱疾病,包括膀胱过度活动症。 它是苯甲酰胺衍生物或其盐,所述衍生物的特征在于包含:苯环; 通过酰胺键与苯环键合的环D(单环或双环烃环或单环或双环杂芳环) 直接键合到苯环上的环E(单环或双环烃环或单环或双环杂芳环) 和通过L(低级亚烷基)与苯环键合的A(氨基部分或单环或双环杂环)。
-
公开(公告)号:EP2085383A4
公开(公告)日:2010-09-22
申请号:EP07831793
申请日:2007-11-14
申请人: ASTELLAS PHARMA INC
发明人: HACHIYA SHUNICHIRO , IKEGAI KAZUHIRO , IBUKA RYOTARO , TAKAHASHI TAISUKE , OKU MAKOTO , SEO RYUSHI , TERADA YOH , SANAGI MASANAO
IPC分类号: C07D211/26 , A61K31/451 , A61K31/4545 , A61P5/18 , A61P5/22 , A61P13/12 , C07D401/04 , C07D401/06 , C07D401/10 , C07D407/06 , C07D409/06 , C07D409/12 , C07D409/14 , C07D417/06
CPC分类号: C07D211/26 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/14 , C07D405/06 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/10 , C07D417/04 , C07D417/06
-
公开(公告)号:EP2172447A4
公开(公告)日:2011-08-24
申请号:EP08790794
申请日:2008-07-02
申请人: ASTELLAS PHARMA INC
发明人: NOZAWA EISUKE , IBUKA RYOTARO , IKEGAI KAZUHIRO , MATSUURA KEISUKE , ZENKOH TATSUYA , SEO RYUSHI
IPC分类号: C07C243/38 , A61K31/195 , A61K31/196 , A61K31/235 , A61K31/245 , A61K31/381 , A61K31/404 , A61K31/416 , A61K31/4192 , A61K31/423 , A61K31/4439 , A61K31/455 , A61K31/4709 , A61K31/538 , A61P3/10 , A61P13/12 , A61P43/00 , C07C233/81 , C07C233/87 , C07D209/08
CPC分类号: C07D209/08 , C07C233/81 , C07C233/87 , C07C235/42 , C07C243/38 , C07C2602/10 , C07D213/80 , C07D231/56 , C07D249/18 , C07D263/56 , C07D265/36 , C07D271/06 , C07D333/38 , C07D401/06 , C07D403/12 , C07D409/06 , C07D409/12 , C07D413/12
-
公开(公告)号:EP3006443A4
公开(公告)日:2016-12-21
申请号:EP14807340
申请日:2014-06-06
申请人: ASTELLAS PHARMA INC
发明人: ISHIHARA TSUKASA , IKEGAI KAZUHIRO , KURIWAKI IKUMI , HISAMICHI HIROYUKI , TAKESHITA NOBUAKI , TAKEZAWA RYUICHI
IPC分类号: C07D409/10 , A61K31/4025 , A61K31/4535 , A61K31/5377 , A61K31/551 , A61P19/02 , A61P21/00 , A61P25/04 , A61P29/00 , A61P43/00 , C07D413/10
CPC分类号: A61K31/5377 , A61K31/4025 , A61K31/4535 , A61K31/551 , C07D409/10 , C07D413/10
摘要: [Problem] A compound which is useful as an IK1 channel activator is provided. [Means for Solution] As a result of studies on the IK1 channel activator, the present inventors have found that a benzothiophene compound shows effectiveness on visceral pain, inflammatory pain, osteoarthritis pain, neuropathic pain, or fibromyalgia, thereby completing the invention. A compound of the invention has an IK1 channel activation effect, and can also be used as an agent for preventing and/or treating visceral pain, inflammatory pain, osteoarthritis pain, neuropathic pain, or fibromyalgia. In addition, the IK1 channel activator can be used as an agent for preventing and/or treating inflammatory pain, osteoarthritis pain, neuropathic pain, and fibromyalgia.
-
公开(公告)号:EP2277858A4
公开(公告)日:2012-06-13
申请号:EP09746580
申请日:2009-05-12
申请人: ASTELLAS PHARMA INC
发明人: NOZAWA EISUKE , IBUKA RYOTARO , IKEGAI KAZUHIRO , MATSUURA KEISUKE , ZENKOH TATSUYA , SEO RYUSHI , WATANUKI SUSUMU , KAGEYAMA MICHIHITO
IPC分类号: C07D215/48 , A61K31/47 , A61P13/12 , C07C233/87 , C07D207/34 , C07D209/08 , C07D217/04 , C07D263/58 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D403/12 , C07D409/12 , C07D409/14
CPC分类号: C07D401/06 , C07C233/47 , C07C233/87 , C07C235/42 , C07C235/52 , C07C235/66 , C07C271/14 , C07C271/22 , C07C2601/02 , C07C2602/08 , C07D207/34 , C07D209/08 , C07D213/64 , C07D215/48 , C07D217/04 , C07D231/14 , C07D235/24 , C07D263/58 , C07D333/68 , C07D333/70 , C07D401/12 , C07D403/12 , C07D405/06 , C07D409/12 , C07D409/14 , C07D413/06 , C07D417/06 , C07D471/04 , C07D491/048
-
-
-
-
-
-